DHC
Diversified Healthcare Trust
There isn't enough reported data to score DHC yet.
DHC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| N/A | |
| N/A |
DHC's revenue and profitability are currently stable. Free cash flow and net leverage aren't meaningful measures for real estate companies like DHC.
DHC PE Valuation
DHC has no meaningful PE right now: it lost money over the past year.
DHC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Stable | |
| Weakening | |
| Limited | |
| High |
Analysts expect DHC's losses to shrink, with revenue holding steady.
DHC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.64 | +$0.83 |
| Q2 2026 | -$1.11 | +$0.09 |
| Q1 2026 | -$1.33 | -$0.10 |
| Q4 2025 | -$1.19 | +$0.36 |
| Q3 2025 | -$1.47 | +$0.14 |
| Q2 2025 | -$1.20 | +$0.28 |
| Q1 2025 | -$1.23 | +$0.14 |
| Q4 2024 | -$1.55 | -$0.32 |
DHC is still losing money, but far less than before: $0.64 per share over the past year, against $1.61 at its worst in late 2024.
DHC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $367.7M | -5.4% |
| Q2 2026 | $365.4M | -4.5% |
| Q1 2026 | $366.5M | -5.3% |
| Q4 2025 | $379.6M | 0% |
| Q3 2025 | $388.7M | +4% |
| Q2 2025 | $382.7M | +3% |
| Q1 2025 | $386.9M | +4.3% |
| Q4 2024 | $379.6M | +5% |
DHC's revenue fell from its 2020 peak and has held roughly level since: $368M last quarter, down 5.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -4% | +24 points |
| Q2 2026 | -0.1% | +9.9 points |
| Q1 2026 | -1.3% | +9.9 points |
| Q4 2025 | -3.7% | +7.1 points |
| Q3 2025 | -28% | -17 points |
| Q2 2025 | -10% | -5.8 points |
| Q1 2025 | -11% | -4 points |
| Q4 2024 | -11% | -1.8 points |
DHC's operating margin was −4% last quarter, up 24 points from the same quarter a year ago.
DHC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $521K | +$90.4M |
| Q2 2026 | $14.2M | -25% |
| Q1 2026 | -$26.8M | +$16.1M |
| Q4 2025 | -$52.5M | -$4M |
| Q3 2025 | -$89.8M | -$63.7M |
| Q2 2025 | $18.8M | +472% |
| Q1 2025 | -$42.9M | -$24.8M |
| Q4 2024 | -$48.5M | +$25.3M |
DHC's free cash flow was −$65M over the past year, against −$162M the year before. Free cash flow isn't a meaningful measure for real estate companies like DHC.
DHC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +231K shares |
| 1 year | +0.2% | +595K shares |
| 3 years | +0.9% | +2.1M shares |
| 5 years | +1.2% | +3M shares |
| Available history | +1.4% | +3.4M shares |
DHC has 241M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2.6M |
| Q2 2026 | $50,000 |
| Q1 2026 | $88,000 |
| Q4 2025 | $82,000 |
| Q3 2025 | $954,000 |
| Q2 2025 | $103,000 |
| Q1 2025 | $6,000 |
| Q4 2024 | $2,000 |
DHC spent $3M buying back its own shares over the past year, up 161% from the year before.
DHC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 10.8x | High |
| Q2 2026 | 18.7x | High |
| Q1 2026 | 25.8x | High |
| Q4 2025 | 41.1x | High |
| Q3 2025 | -4.4x | Net Cash |
| Q2 2025 | -1.2x | Net Cash |
| Q1 2025 | -2.2x | Net Cash |
| Q4 2024 | 18.3x | High |
DHC's net debt is about 11 years of its operating earnings (EBITDA), after holding more cash than debt a year ago. Net leverage isn't a meaningful measure for real estate companies like DHC.
DHC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.1 | Neutral |
| Stochastic | 20.5 | Neutral |
DHC's weekly RSI is 44 (neutral) and its Stochastic is 21 (neutral).
DHC PE vs Real Estate Sector
| Metric | DHC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
DHC has no meaningful PE right now: it lost money over the past year.
DHC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.61 | 4.2% below |
| 20 week MA | $8.11 | 10% below |
| 50 week MA | $7.39 | 1.4% below |
| 100 week MA | $5.33 | 37% above |
| 200 week MA | $3.88 | 88% above |
DHC has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 88% above its 200-week average.
DHC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.95 | $4.16 | -48% |
| 2021 | $4.16 | $2.67 | -36% |
| 2022 | $2.67 | $0.66 | -75% |
| 2023 | $0.66 | $3.74 | +467% |
| 2024 | $3.74 | $2.17 | -42% |
| 2025 | $2.17 | $4.80 | +121% |
| 2026 YTD | $4.80 | $7.29 | +52% |
DHC's yearly returns have swung widely, from +467% in 2023 to −75% in 2022. It's up 52% so far in 2026.